30 years ago last week, the US Orphan Drug Act came into being, and with it, a door of possibilities opened up for patients with literally thousands of untreated diseases. The anniversary marks the beginning of a journey where medicines for rare diseases have gained a foothold in the portfolios of drug companies large and [...]
PharmExec Blog
Follow Us
RSS
Bookstore
The Orphan Drug Act at 30 Years: What's Next?